Skip to main content

Table 1 Comparisons major cytokines related with regulation the bone resorption between patients with Thalassemia major and healthy controls

From: Assessment of biochemical bone markers of osteoporosis in children with thalassemia major

 

β -TM group

(n = 38)

Control group

(n = 40)

P

Age (y)

(mean ± SD)

12.92 ± 3.10

12.50 ± 3.12

t = −  0.596

p = 0.553

DPD (nM/mM Kr)

(mean ± SD)

44.57 ± 24.14

51.29 ± 31.06

t = 1.069

p = 0.289

Beta-CTx (pg/mL)

(mean ± SD)

1025.76 ± 439.71

968.00 ± 388.46

t = −  0.614

P = 0.541

OPG (pmol/L)

(mean ± SD)

2.01 ± 0.66

2.43 ± 0.57

t = 3.027

p = 0.003

RANKL (pmol/L)

(mean ± SD)

346.18 ± 142.63

318.05 ± 110.75

t = − 0.976

p = 0.332

RANKL/OPG

46.09

33.24

p = 0.012

  1. DPD Deoxypyridinoline, OPG Osteoprotegerin, RANKL Receptor activator of NF-κB ligand, β –TM Beta-thalassemia, Beta-CTx Beta-Crosslaps